Neuropathology of dementia in Parkinson's disease: A prospective, community-based study

Annals of Neurology

Volumn 58, Issue 5, 2005, Pages 773-776

  Aarsland, Dag ^a,b   Perry, Robert ^c   Brown, Andrew ^c   Larsen, Jan P ^a,b   Ballard, Clive ^d  

^a STAVANGER UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

^c NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

^d KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; AUTOPSY; CLINICAL ARTICLE; CLINICAL FEATURE; COGNITION; COGNITIVE DEFECT; COMMUNITY CARE; CONTROLLED STUDY; DEATH; DEMENTIA; DISEASE ACTIVITY; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; LEWY BODY; LIMBIC CORTEX; MALE; NEUROPATHOLOGY; PARKINSON DISEASE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCORING SYSTEM;

AGED; AGED, 80 AND OVER; COGNITION DISORDERS; DEMENTIA; DEMOGRAPHY; FEMALE; HUMANS; LEWY BODIES; MALE; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; RESIDENCE CHARACTERISTICS; SENILE PLAQUES;

EID: 27644456601     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.20635     Document Type: Article

References (19)

1. Jellinger KA, Seppi K, Wenning GK, Poewe W. Impact of coexistent Alzheimer pathology on the natural history of Parkinson's disease. J Neural Transm 2002;109:329-339.
2. Apaydin H, Ahlskog JE, Parisi JE, et al. Parkinson disease neuropathology: later-developing dementia and loss of the levodopa response. Arch Neurol 2002;59:102-112.
3. Hurtig HI, Trojanowski JQ, Galvin J, et al. Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson's disease. Neurology 2000;54:1916-1921.
4. Mattila PM, Rinne JO, Helenius H, et al. Alpha-synuclein-immunoreactive cortical Lewy bodies are associated with cognitive impairment in Parkinson's disease. Acta Neuropathol (Berl) 2000;100:285-290.
5. Harding AJ, Halliday GM. Cortical Lewy body pathology in the diagnosis of dementia. Acta Neuropathol (Berl) 2001;102:355-363.
6. Aarsland D, Ballard CG, Halliday G. Are Parkinson's disease with dementia and dementia with Lewy bodies the same entity? J Geriatr Psychiatry Neurol 2004;17:137-l45.
7. Tandberg E, Larsen JP, Nessler EG, et al. The epidemiology of Parkinson's disease in the county of Rogaland, Norway. Mov Disord 1995;10:541-549.
8. Larsen JP, Dupont E, Tandberg E. Clinical diagnosis of Parkinson's disease. Proposal of diagnostic subgroups classified at different levels of confidence. Acta Neurol Scand 1994;89:242-251.
9. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (revised). 3rd ed. Washington, DC: APA, 1987.
10. Folstein MF, Folstein SE, McHugh PR. "Mini-Mental State." A practical method for grading the mental state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
11. Aarsland D, Andersen K, Larsen JP, et al. Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. Arch Neurol 2003;60:387-392.
12. McKeith IG, Galasko D, Kosaka K, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the Consortium on DLB International Workshop. Neurology 1996;47:1113-1124.
13. Gelb DJ, Oliver E, Gilman S. Diagnostic criteria for Parkinson disease. Arch Neurol 1999;56:33-39.
14. Mirra SS. The CERAD neuropathology protocol and consensus recommendations for the postmortem diagnosis of Alzheimer's disease: a commentary. Neurobiol Aging 1997;18:S91-S94.
15. Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease. Neurobiol Aging 1997;18:S1-S2.
16. Mirra SS, Heyman A, McKeel D, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991;41:479-486.
17. Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (Berl) 1991;82:239-259.
18. Perry RH, Jaros E, Hall RA, et al. Proposal for modification of consensus guidelines for the neuropathological diagnosis of dementia with Lewy bodies (DLB) when using alfa-synuclein immunohistochemistry. Third International Workshop on Dementia with Lewy Bodies and Parkinson's Disease Dementia. Newcastle upon Tyne, UK, 2003:158.
19. Perry RH, Irving D, Tomlinson BE. Lewy body prevalence in the aging brain: relationship to neuropsychiatric disorders, Alzheimer-type pathology and catecholaminergic nuclei. J Neurol Sci 1990;100:223-233.